COLON-MD: Colon Cancer Longitudinal Study
ConditionColon Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-79
SponsorBaylor Research Institute
About this trial
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Eligibility criteria
Qualifiers
Colon cancer diagnosis
Age >18 and < or equal to 79.
Ability to perform informed consent
FOLFOX treatment expected
Disqualifiers
Not Pregnant
Does not have Lynch syndrome or FAP diagnosis.
Inability to perform inform consent
inability to comply with follow up program
Trial design
Treatments tested in this trial
- Not listed
Trial groups
11 Participants
are grouped into 1 trial groupSponsors and collaborators
Baylor Research Institute
Lead sponsor
Baylor University
Collaborator
Source ClinicalTrials.gov